NEW YORK (360Dx) – PTS Diagnostics announced today the US Food and Drug Administration cleared the company's medical device convenience kit for quantitatively measuring the percent of glycated hemoglobin, total cholesterol, high-density lipoprotein, triglycerides, and glucose in whole blood.

The Indianapolis-based firm said that the kits will be the product aspect for its PreVantage suite of products, strategies, and partnerships for healthcare organizations.